Xolair 300 MG/2 ML autoinject 2ML

Ended Awarded Last action

Contract number
SPE2DR26FMEM6
Awardee
Awarding agency
Obligated
$41,939

Award facts

Contract value 100% obligated
$41,938.56 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The Defense Logistics Agency issued a $41,938.56 delivery order to DMS Pharmaceutical Group Inc. on February 27, 2026, for Xolair 300 mg/2 ml autoinjector supply, with an ultimate completion date of March 20, 2026.

The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), DLA's indefinite delivery contract vehicle for pharmaceutical supply to Department of Defense medical facilities worldwide. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. Place of performance is Park Ridge, Illinois.

Quick answers

Who was awarded contract SPE2DR26FMEM6?

SPE2DR26FMEM6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on February 27, 2026.

How much is contract SPE2DR26FMEM6 worth?

The government has obligated $41,939 on SPE2DR26FMEM6.

Is contract SPE2DR26FMEM6 an order under another contract?

Yes. SPE2DR26FMEM6 is a delivery order under SPE2DR25D9114, an indefinite delivery contract.

Was contract SPE2DR26FMEM6 competed?

The extent of competition for SPE2DR26FMEM6 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login